Publications
Symptom Dimension of Interest-Activity Indicates Need for Aripiprazole Augmentation of Escitalopram in Major Depressive Disorder: A CAN-BIND-1 Report.. J Clin Psychiatry. 81(4)
.
2020. A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: a research protocol.. BMC Psychiatry. 19(1):285.
.
2019. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study.. Lancet. 387(10023):1085-93.
.
2016. Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression.. Depress Anxiety. 31(5):451-7.
.
2014. Combined treatment: impact of optimal psychotherapy and medication in bipolar disorder.. Bipolar Disord. 17(1):86-96.
.
2015. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.. Bipolar Disord. 7 Suppl 3:5-69.
.
2005. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder.. Front Psychiatry. 9:207.
.
2018.